Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

MorphoSys and Incyte sign $900m deal for B-cell malignancies drug

pharmaceutical-technologyJanuary 15, 2020

Tag: MorphoSys , Incyte , B-cell malignancies

PharmaSources Customer Service